Combining Inpatient and Outpatient Data for Diagnosis of Non-Valvular Atrial Fibrillation Using Electronic Health Records: A Validation Study

Purpose Previous studies have demonstrated differences in atrial fibrillation (AF) detection based on data from hospital sources without data from outpatient sources. We investigated the detection of documented diagnoses of non-valvular AF in a large Israeli health-care organization using electronic health record data from multiple sources. Patients and Methods This was an open-chart validation study. Three distinct algorithms for identifying AF in electronic health records, differing in the source of their International Classification of Diseases, Ninth Revision code and use of the associated free text, were defined. Algorithm 1 incorporated inpatient data with outpatient data and the associated free text. Algorithm 2 incorporated inpatient and outpatient data regardless of the free text associated with AF diagnosis. Algorithm 3 used only inpatient data source. These algorithms were compared to a gold standard and their sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated. To establish the gold standard (documentation of arrhythmia based on electrocardiography interpretation or a cardiologist’s written diagnosis), 200 patients at highest risk for having non-valvular AF were randomly selected for open-chart validation by two physicians. Results The algorithm that included hospital settings, outpatient settings, and incorporated associated free text in the outpatient records had the optimal balance between all validation measures, with a high level of sensitivity (85.4%), specificity (95.0%), PPV (81.4%), and NPV (96.2%). The alternative algorithm that combined inpatient and outpatient data without free text also performed better than the algorithm that included only hospital data (82.9%, 95.0%, 81.0%, and 95.6%, compared to 70.7%, 96.9%, 85.3%, and 92.8%, sensitivity, specificity, PPV, and NPV, respectively). Conclusion In this study, involving a comprehensive data collection from inpatient and outpatient sources, incorporating outpatient data with inpatient data improved the diagnosis of non-valvular AF compared to inpatient data alone.

[1]  A. Garg,et al.  Incident Atrial Fibrillation and the Risk of Congestive Heart Failure, Myocardial Infarction, End-Stage Kidney Disease, and Mortality Among Patients With a Decreased Estimated GFR. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  David W. Bates,et al.  Use of electronic healthcare records to identify complex patients with atrial fibrillation for targeted intervention , 2016, J. Am. Medical Informatics Assoc..

[3]  J. Healey,et al.  Identifying Patients With Atrial Fibrillation in Administrative Data. , 2016, The Canadian journal of cardiology.

[4]  H. Bøtker,et al.  Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study , 2016, BMJ Open.

[5]  Moshe Hoshen,et al.  Prospective National Study of the Prevalence, Incidence, Management and Outcome of a Large Contemporary Cohort of Patients With Incident Non‐Valvular Atrial Fibrillation , 2015, Journal of the American Heart Association.

[6]  C. Murray,et al.  Worldwide Epidemiology of Atrial Fibrillation: A Global Burden of Disease 2010 Study , 2014, Circulation.

[7]  J. Olgin,et al.  Incident Atrial Fibrillation Among Asians, Hispanics, Blacks, and Whites , 2013, Circulation.

[8]  D Kalra,et al.  Electronic health records: new opportunities for clinical research , 2013, Journal of internal medicine.

[9]  S. Brunak,et al.  Mining electronic health records: towards better research applications and clinical care , 2012, Nature Reviews Genetics.

[10]  K. Overvad,et al.  Validity of the diagnoses atrial fibrillation and atrial flutter in a Danish patient registry , 2012, Scandinavian cardiovascular journal : SCJ.

[11]  James Floyd,et al.  A systematic review of validated methods for identifying atrial fibrillation using administrative data , 2012, Pharmacoepidemiology and drug safety.

[12]  Elsayed Z Soliman,et al.  Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. , 2009, American heart journal.

[13]  Wansu Chen,et al.  Racial/Ethnic Differences in Ischemic Stroke Rates and the Efficacy of Warfarin Among Patients With Atrial Fibrillation , 2008, Stroke.

[14]  Serguei V. S. Pakhomov,et al.  Epidemiology of angina pectoris: role of natural language processing of the medical record. , 2007, American heart journal.

[15]  B. Psaty,et al.  Newly detected atrial fibrillation and compliance with antithrombotic guidelines. , 2007, Archives of internal medicine.

[16]  R. Cebul,et al.  Failure to prescribe warfarin to patients with nonrheumatic atrial fibrillation , 1996, Journal of General Internal Medicine.

[17]  T. Lumley,et al.  Risk of new-onset atrial fibrillation in relation to body mass index. , 2006, Archives of internal medicine.

[18]  E. Ellerbeck,et al.  Combined Anticoagulant–Antiplatelet Use and Major Bleeding Events in Elderly Atrial Fibrillation Patients , 2004, Stroke.

[19]  D. Berlowitz,et al.  Identifying Hypertension-Related Comorbidities From Administrative Data: What's the Optimal Approach? , 2004, American journal of medical quality : the official journal of the American College of Medical Quality.

[20]  S. Gaehde,et al.  Anticoagulant Use for Atrial Fibrillation in the Elderly , 2004, Journal of the American Geriatrics Society.

[21]  Yuchiao Chang,et al.  Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice? , 2003, JAMA.

[22]  D. Singer,et al.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. , 2001, JAMA.

[23]  B. Griffith,et al.  Atrial fibrillation: prevalence after minimally invasive direct and standard coronary artery bypass. , 2001, The Annals of thoracic surgery.

[24]  I. Kronzon,et al.  Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation. , 2001, Circulation.

[25]  D. Singer,et al.  Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study. , 2000, Circulation.

[26]  B. Gage,et al.  Underutilization of antithrombotic therapy in elderly rural patients with atrial fibrillation. , 1999, American heart journal.

[27]  D. Einstadter,et al.  Atrial fibrillation as a risk factor for stroke: a retrospective cohort study of hospitalized Medicare beneficiaries. , 1998, American journal of public health.

[28]  H. Krumholz,et al.  Warfarin use among patients with atrial fibrillation. , 1997, Stroke.

[29]  L H Kuller,et al.  Incidence of and risk factors for atrial fibrillation in older adults. , 1997, Circulation.

[30]  J. Whittle,et al.  Is warfarin underused in the treatment of elderly persons with atrial fibrillation? , 1997, Archives of internal medicine.